Company / Revenue per Share
Amphstar Pharmaceuticals, Inc. Revenue per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$15.12
FY2025
5-year range
$9.22 / $15.23
FY2021-FY2025
Trend
-0.7%
vs FY2024
Sector context
#35 of 154
Health Care
What the data says
Amphstar Pharmaceuticals, Inc.'s revenue per share of $15.12 is higher than 77% of companies in the Health Care sector (FY2025). Improved from $13.39 to $15.12 over the past 2 years.
Based on SEC 10-K filings.
15.12 in FY2025 with a 5-year CAGR of +15.0%. Top quartile in the Health Care sector.
Improved from $13.39 to $15.12 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +13.1%
- 5-Year CAGR
- +15.0%
- 10-Year CAGR
- -
Sector benchmark
In line with sector averageTop 23% of 154This company $15.12 Sector average $15.09
▼
In line with sector average
Key checks
Key Insights
- In FY2025, revenue per share decreased 0.7% year-over-year.
- Ranks #35 out of 154 companies in the Health Care sector.
- Peak revenue per share was recorded in FY2024.
- Lowest revenue per share in the period was in FY2017.
Company context
Key Data Points
- Strong profit margin: 21.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $15.12 | -0.7% |
| FY2024 | $15.23 | +13.7% |
| FY2023 | $13.39 | +28.1% |
| FY2022 | $10.46 | +13.5% |
| FY2021 | $9.22 | +22.7% |
| FY2020 | $7.51 | +8.7% |
| FY2019 | $6.91 | +9.4% |
| FY2018 | $6.32 | +21.7% |
| FY2017 | $5.19 | -8.0% |
| FY2016 | $5.65 | +0.2% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026